Table 4. Mean changes in the probing depth, relative attachment level and intrabony defect depth reduction over a 9-month period in the groups .
| Parameter | 1.2% ATV | 1.2% SMV | Placebo | P-value | |
| Mean PD change | Placebo vs 1.2% ATV | <0.001* | |||
| 3.37 ± 1.32 | 3.10 ± 1.55 | 1.25 ± 1.24 | Placebo vs 1.2% SMV | <0.001* | |
| 1.2% ATV vs 1.2% SMV | 0.620 | ||||
| Mean RAL change | Placebo vs 1.2% ATV | <0.001* | |||
| 3.46 ± 1.47 | 3.13 ± 1.56 | 1.30 ± 1.51 | Placebo vs 1.2% SMV | <0.001* | |
| 1.2% ATV vs 1.2% SMV | 0.674 | ||||
| Placebo vs 1.2% ATV | <0.001* | ||||
| 1.69 ± 0.34 | 1.53 ± 0.41 | 0.12 ± 0.10 | Placebo vs 1.2% SMV | <0.001* | |
| Mean IBD change | 1.2% ATV vs 1.2% SMV | 0.153 |
*Statistically significant at P<0.0